RegCell

A regulatory T cell-based immune system control technology that addresses autoimmune diseases and cancer by enabling new methods of immune regulation. It is intended to provide new medical treatments for these conditions, but the specific target customer roles, segments, or company sizes are not specified in the provided text. It is positioned as a novel immune regulation approach using regulatory T cells, with no explicit delivery model or comparison to alternatives detailed.